Brown-Forman Corporation has revealed its new Managing Director for Australia, New Zealand and Pacific Island (ANZPI) will be Eveline Albarracin, who will commence the role 15 January 2020.
Albarracin, who brings more than 20 years of experience in healthcare and consumer goods to the role, succeeds Marc Satterthwaite who retired recently.
Speaking about the appointment Marshall Farrer, Brown-Forman, Senior Vice President, Global Travel Retail and Developed APAC, said: “Eveline’s experience in building brands and leading strategic projects equips her well to guide this important market.
“We believe Eveline will bring an outstanding set of leadership skills, valuable and diverse experiences, and a difference-making approach to our critically important ANZPI business.”
Albarracin joins Brown-Forman from Galderma (Nestlé Skin Health) where she most recently served as Managing Director for Australia & New Zealand and prior to that served as the Business Unit Head for Prescription. Prior to Galderma, Eveline worked for Actavis (now Allergan) and Valeant Pharmaceuticals where she held various leadership roles across both sales and marketing.
Brown-Forman said that she will manage and direct the organisation in ANZPI “to achieve optimum profitability and sales targets by responsibly building B-F brands within the markets”.
The corporation added: “She will lead strategic projects to grow the business through portfolio, pricing, route-to-market, resource allocation, and disciplined decision making.”
Albarracin, who will be based in Sydney, earned her Bachelor of Science degree in Physiology and Pharmacology from the University of Queensland and has completed advanced finance and business management studies at the University of Queensland and the Australian Institute of Management in Sydney.
She will serve on the Global Travel Retail & Developed APAC Regional Leadership Team, providing leadership to brand building strategies and partnership engagement.